TFX250117P190000
- 0.00
- 0.000.00%
Teleflex Newsroom
Express News | Teleflex Awarded Short Term Central Venous Catheters Contract From Vizient
RBC Capital Maintains Teleflex(TFX.US) With Buy Rating, Maintains Target Price $220
How Is The Market Feeling About Teleflex?
Teleflex to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
P/E Ratio Insights for Teleflex
Teleflex Incorporated's (NYSE:TFX) Price In Tune With Earnings
Teleflex Inc. Stock Underperforms Tuesday When Compared To Competitors
Should You Retain Teleflex Stock in Your Portfolio Right Now?
RBC Capital Maintains Teleflex(TFX.US) With Buy Rating, Cuts Target Price to $220
Teleflex Is Maintained at Hold by Truist Securities
Truist Financial Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $200
RBC Cuts Price Target on Teleflex to $220 From $245, Keeps Outperform Rating
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
Mizuho Securities Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $230
Express News | Teleflex Inc : Mizuho Cuts Target Price to $230 From $250
Worst Performing Stocks for Tax Loss Selling – Wolfe
Teleflex Reportedly in Talks to Buy Biotronik Stent Business
Needham Reiterates Hold on Teleflexto Hold